Avexegen Therapeutics

About:

Avexegen Therapeutics is a biotechnology company developing therapies for gastrointestinal disorders.

Top Investors: Mission BioCapital, National Institutes of Health, Small Business Innovation Research, BioInnovation

Description:

Avexegen Therapeutics develops revolutionary therapies to promote gastro-intestinal health for patients with GI disorders. They offer an approach to directly heal damaged and inflamed gut tissue in patients with crohns disease and ulcerative colitis, as well as in premature infants with necrotizing enterocolitis.

Total Funding Amount:

$3.17M

Estimated Revenue Range:

$1B to $10B

Headquarters Location:

San Diego, California, United States

Founded Date:

2014-01-01

Founders:

Soumitra Ghosh

Number of Employees:

1-10

Last Funding Date:

2021-02-15

IPO Status:

Private

Industries: